Location: Home
  • search
  • go
  • Relate News
  • 9/26/2023CDE Solicits Comments on the Technical Guidelines for the Assessment o...
  • 9/26/2023SAMR Imposed Fines and Confiscations Totaling Over CNY 300 Million in...
  • 9/26/2023Control Dispute with Hengrui Led to Dissolution Drama of Reistone Biop...
  • 9/26/2023Chinese Patents of Four MNC Originator Drugs Face Imminent Invalidatio...
  • 9/26/2023WuXi Debuts First Vaccine CDMO Site in China
  • 9/26/2023Patent Linkage In China: What The First Decisions Reveal About The Dir...
  • 9/26/2023AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happe...
  • 9/25/2023CDE Solicits Comments on the Acceptance and Review Guide to GQCE Studi...
  • 9/25/2023CDE's Annual Review of Chinese Drug Evaluation and Registration in 202...
  • 9/25/2023AbbVie Terminates Deal with I-Mab to Exit Race for CD47 Space
  • 9/25/2023CDE Solicits Comments on the Technical Guidelines for Clinical Trial o...
  • 9/24/2023Chime Biologics Enter Global Strategic Deal with Panolos for Multi-spe...
  • 9/24/2023PackGene and Kudo Partner to Offer Customized mRNA Manufacturing Servi...
  • 9/24/2023Six Central Government Agencies Issue A New Batch of Rare Disease Cata...
  • 9/24/2023Strategies for Asian Business Navigating a New Era (McKinsey)
  • 9/24/2023Improving Access to Medicines and Beyond: the National Volume-based Pr...
  • 9/21/2023Meitheal Licenses U.S. Rights of Insulin Biosimilars from Tonghua Dong...
  • 9/21/2023Drug R&D and Product Registration News Digest 09/2023 (3)
  • 9/21/2023Recent Executive Moves
  • 9/20/2023NHSA Clears Two Additional Drugs from Form Evaluation for 2023 NRDL In...
  • 9/20/2023Everest Medicines Enters into Collaboration and License Agreement with...
  • 9/20/2023IQVIA: Chinese Hospital Drug Market Rebounded in MAT Q2/2023
  • 9/20/2023A Share-Listed Chinese MedPharm Cos Report Broadly Positive Performanc...
  • 9/20/2023CDE Solicits Comments on the Technical Guidelines for Pharmaceutical R...
  • 9/20/2023CDE Solicits Comments on the Technical Guidelines for Non-Clinical Res...
  • 9/20/2023CDE Publicizes the List of Reference Formulations for GQCE Studies (74...
  • 9/20/2023Chinese Drugmakers Hit a Fundraising and Licensing Slump in August (Ph...
  • 9/19/2023Researchers Must Navigate Thorny New Data Security Laws (UWN)
  • 9/19/2023CDE Solicits Comments for the Latest Adjustment Catalog of Reference F...
  • 9/19/2023CDE Solicits Comments on the Dossier Requirements for Communication an...
  • Page:91/777 Total number of articles:23297: [First][<<] [89] [90] [91] [92] [93] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group